<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2024-09-30</publicationDate>
    
        <volume>17</volume>
        <issue>3</issue>

 
    <startPage>1445</startPage>
    <endPage>1459</endPage>

	 
      <doi>10.13005/bpj/2955 </doi>
        <publisherRecordId>60599</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Intranasal Administration of Standardized Extract of Gotu Kola Leaves Against Nitroglycerine-Induced Recurrent Migraine-Like Pain in Rats</title>

    <authors>
	 


      <author>
       <name>Prasad Arvind Thakurdesai</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Pooja Abhay Bhalerao</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Urmila Manoj Aswar</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Scientific Affairs, Indus Biotech Limited, Pune, India</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">The present study aimed to determine the efficacy of intranasal administration of a standardized extract of Gotu kola, i.e., C<em>entella asiatica</em> (L.) Urban (INDCA-NS) with marker triterpenoids for the prevention of nitroglycerine- (NTG)-induced recurrent migraine in rats. Adult rats of both sexes in a group of 12 were administered intraperitoneal NTG (10 mg/kg) on alternate days (D1 to D9) and once daily intranasal solutions of either vehicle (saline, 50 µL/rat/day), sumatriptan (80 µL/rat/day of 12 mg/ml) as positive control, or INDCA-NS (10, 30, or 100 µg/rat/day) for 21 days. Behavioral and biochemical parameters related to concurrent migraine pain (facial expressions on the grimace scale, thermal hyperalgesia, mechanical allodynia, and plasma and brain levels of pituitary adenylate cyclase-activating polypeptide and nitric oxide), and stress (photophobia and cortisol levels in the brain and serum) were measured. The intranasal administration of INDCA-NS prevented NTG-induced migraine-like pain, photophobia, and stress in a dose-dependent manner. At the same time, sumatriptan alleviated pain and anxiety but not photophobia. In conclusion, the intranasal administration of INDCA-NS showed prophylactic efficacy against recurrent NTG-induced migraine pain in rats.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol17no3/intranasal-administration-of-standardized-extract-of-gotu-kola-leaves-against-nitroglycerine-induced-recurrent-migraine-like-pain-in-rats/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Anti-nociception</keyword>
      

      
        <keyword> Centella asiatica (L.) Urban leaves</keyword>
      

      
        <keyword> Gotu kola</keyword>
      

      
        <keyword> Recurrent migraine</keyword>
      
</keywords>
  </record>
</records>